Drug Profile
FPA 144 companion diagnostics - Five Prime Therapeutics
Latest Information Update: 28 Sep 2021
Price :
$50
*
At a glance
- Originator Five Prime Therapeutics
- Class Diagnostic agents; Protein diagnostics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Gastric cancer